ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ClinicalTrials.gov ID: NCT07571005

Public ClinicalTrials.gov record NCT07571005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure (AMAZE 3)

Study identification

NCT ID
NCT07571005
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • NNC0487-0111 Drug
  • Placebo (matched to NNC0487-0111) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 4, 2026
Primary completion
Jul 11, 2028
Completion
Oct 3, 2028
Last update posted
May 5, 2026

2026 – 2028

United States locations

U.S. sites
17
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
Artemis Insitute for Clin Res San Diego California 92123
PharmaDev Clinical Research Institute LLC Miami Florida 33176
Essence MD Research Naples Florida 34102
Ocala Lung & Critical Care Associates Ocala Florida 34471
NeuroTrials Research, Inc. Atlanta Georgia 30328
Physicians Research Associates Lawrenceville Georgia 30046
University Of Chicago Chicago Illinois 60637
Weil Cornell Medicine New York New York 10021
CTI Clinical Research Center Cincinnati Ohio 45212
Clinical Research Associates of Central PA, LLC DuBois Pennsylvania 15801
Epic Medical Research DeSoto Texas 75115
Advanced Neurology Epilepsy and Sleep Center ANESC El Paso Texas 79912
Biorhythms Center for Integrative Sleep Medicine El Paso Texas 79912
Houston Pulmonary Medicine Associates, PA Houston Texas 77089
Sleep Therapy Research Center San Antonio Texas 78229
Tricoastal Sleep Center Sugar Land Texas 77478
Rainier Clin Res Ctr Inc Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07571005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07571005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →